These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10941692)

  • 21. Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity.
    Miedema MD; Huguelet J; Virani SS
    Curr Atheroscler Rep; 2016 Jan; 18(1):4. PubMed ID: 26753770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of refusal during a multi-step recruitment process for a randomized controlled trial of arthritis education.
    Blanch DC; Rudd RE; Wright E; Gall V; Katz JN
    Patient Educ Couns; 2008 Nov; 73(2):280-5. PubMed ID: 18715740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
    Lee IM; Cook NR; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):56-65. PubMed ID: 15998891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does walking decrease the risk of cardiovascular disease hospitalizations and death in older adults?
    LaCroix AZ; Leveille SG; Hecht JA; Grothaus LC; Wagner EH
    J Am Geriatr Soc; 1996 Feb; 44(2):113-20. PubMed ID: 8576498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).
    Nelson M; Reid C; Beilin L; Donnan G; Johnston C; Krum H; Storey E; Tonkin A; McNeil J;
    Drugs Aging; 2003; 20(12):897-903. PubMed ID: 14565783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A health-economic evaluation of aspirin: primary prevention and cardiovascular disease.
    Sakai T; Saku K
    Intern Med; 2007; 46(8):431-3. PubMed ID: 17443030
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Method for Recruiting Representative At-Risk Individuals into Cancer Prevention Trials: Online Health Risk Assessment in Employee Wellness Programs.
    Hui SK; Miller SM; Hazuda L; Engelman K; Ellerbeck EF
    J Cancer Educ; 2016 Sep; 31(3):421-9. PubMed ID: 26507744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of recruitment strategies for a large-scale clinical trial in the elderly.
    Silagy CA; Campion K; McNeil JJ; Worsam B; Donnan GA; Tonkin AM
    J Clin Epidemiol; 1991; 44(10):1105-14. PubMed ID: 1941003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
    Pradhan AD; Cook NR; Manson JE; Ridker PM; Buring JE
    Diabetes Care; 2009 Jan; 32(1):3-8. PubMed ID: 18835953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial.
    Effoe VS; Katula JA; Kirk JK; Pedley CF; Bollhalter LY; Brown WM; Savoca MR; Jones ST; Baek J; Bertoni AG;
    Trials; 2016 Oct; 17(1):496. PubMed ID: 27733193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recruiting community health centers into pragmatic research: Findings from STOP CRC.
    Coronado GD; Retecki S; Schneider J; Taplin SH; Burdick T; Green BB
    Clin Trials; 2016 Apr; 13(2):214-22. PubMed ID: 26419905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force.
    Guirguis-Blake JM; Evans CV; Senger CA; O'Connor EA; Whitlock EP
    Ann Intern Med; 2016 Jun; 164(12):804-13. PubMed ID: 27064410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
    Mora S; Manson JE
    JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline characteristics of participants in the Women's Health Study.
    Rexrode KM; Lee IM; Cook NR; Hennekens CH; Buring JE
    J Womens Health Gend Based Med; 2000; 9(1):19-27. PubMed ID: 10718501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial.
    Daly M; Seay J; Balshem A; Lerman C; Engstrom P
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):413-6. PubMed ID: 1305474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rise and fall of aspirin in the primary prevention of cardiovascular disease.
    Raber I; McCarthy CP; Vaduganathan M; Bhatt DL; Wood DA; Cleland JGF; Blumenthal RS; McEvoy JW
    Lancet; 2019 May; 393(10186):2155-2167. PubMed ID: 31226053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruiting physicians for office-based research.
    Levinson W; Dull VT; Roter DL; Chaumeton N; Frankel RM
    Med Care; 1998 Jun; 36(6):934-7. PubMed ID: 9630134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status and the consistency analysis of using two criteria for decision making of aspirin use for the primary prevention of ischemic cardiovascular disease in outpatients].
    Zuo HJ; Deng LQ; Wang JW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):298-303. PubMed ID: 29747326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.